Neuropsychiatric events following high-dose steroid administration during early immune checkpoint therapy are more frequent with extended steroid exposure

Patients on immune checkpoint therapy (ICT) are at risk for neuropsychiatric events due to the use of steroids in managing immune-related adverse effects. We aimed to characterize neuropsychiatric events after the initial administration of high-dose steroids following early ICT.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lacourt, Tamara E. (Verfasst von) , Schubert, Marc Cicero (Verfasst von) , Siddiqui, Bilal A. (Verfasst von) , Subudhi, Sumit K. (Verfasst von) , Chopra, Deepti A. (Verfasst von)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 08 November 2025
In: Supportive care in cancer
Year: 2025, Jahrgang: 33, Heft: 12, Pages: 1-9
ISSN:1433-7339
DOI:10.1007/s00520-025-10083-x
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00520-025-10083-x
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s00520-025-10083-x?utm_source=getftr&utm_medium=getftr&utm_campaign=getftr_pilot&getft_integrator=clarivate
Volltext
Verfasserangaben:Tamara E. Lacourt, Marc C. Schubert, Bilal A. Siddiqui, Sumit K. Subudhi, Deepti A. Chopra
Beschreibung
Zusammenfassung:Patients on immune checkpoint therapy (ICT) are at risk for neuropsychiatric events due to the use of steroids in managing immune-related adverse effects. We aimed to characterize neuropsychiatric events after the initial administration of high-dose steroids following early ICT.
Beschreibung:Gesehen am 20.02.2026
Beschreibung:Online Resource
ISSN:1433-7339
DOI:10.1007/s00520-025-10083-x